Texas 2025 - 89th Regular

Texas House Bill HB3455 Latest Draft

Bill / Introduced Version Filed 02/27/2025

Download
.pdf .doc .html
                            89R14542 SCL-D
 By: Shofner H.B. No. 3455




 A BILL TO BE ENTITLED
 AN ACT
 relating to manufacturer disclosure requirements and liability for
 experimental drugs and devices.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  Subchapter E, Chapter 431, Health and Safety
 Code, is amended by adding Section 431.118 to read as follows:
 Sec. 431.118.  EXPERIMENTAL DRUG OR DEVICE DISCLOSURE
 REQUIREMENTS; LIABILITY. (a) In this section, "experimental drug
 or device" means a drug or device that:
 (1)  is experimental or investigational; or
 (2)  has been approved by the United States Food and
 Drug Administration for emergency use.
 (b)  A manufacturer of an experimental drug or device shall
 provide to a purchaser of the drug or device a disclosure form that
 provides a consumer all information reasonably necessary for the
 consumer to make an informed decision on whether to use the drug or
 device, including possible adverse health effects of the drug or
 device, in a clear and coherent summary.
 (c)  A purchaser of an experimental drug or device shall
 provide the disclosure form described by Subsection (b) to a person
 to whom the purchaser sells the drug or device. A health care
 provider or retailer providing or selling the drug or device to a
 consumer:
 (1)  shall provide the disclosure form in person to the
 consumer; and
 (2)  may provide or sell the drug or device to the
 consumer only if a person capable of providing informed consent for
 the ultimate consumer of the drug or device signs the disclosure.
 (d)  A consumer who receives an experimental drug or device
 in violation of this section may bring an action against the
 manufacturer of the drug or device for damages arising from an
 adverse effect of the drug or device.
 (e)  A prevailing claimant in an action brought under
 Subsection (d) may recover:
 (1)  compensatory damages, including damages for
 physical and emotional pain and suffering;
 (2)  exemplary damages; and
 (3)  reasonable attorney's fees and costs incurred in
 bringing the action.
 SECTION 2.  Section 431.118, Health and Safety Code, as
 added by this Act, applies only to a cause of action that accrues on
 or after the effective date of this Act.
 SECTION 3.  This Act takes effect September 1, 2025.